A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Jan 2018
At a glance
- Drugs Brincidofovir (Primary)
- Indications Adenovirus infections; Cytomegalovirus infections; Monkeypox; Smallpox; Viral infections
- Focus Adverse reactions
- Sponsors Chimerix
- 05 Jan 2018 According to a Chimerix media release, the company expects to provide data in the second half of 2018.
- 05 Jan 2018 Status changed from recruiting to completed, according to a Chimerix media release.
- 08 Nov 2017 According to a Chimerix media release, data will be reported in early 2018.